Scimex: US researchers have found that exercise can slow the growth of breast
cancer tumours in mice. They also saw that in mice that exercised,
tumours responded better to anti-cancer drugs compared with those that
did not exercise. The authors suggest that this is because more blood
vessels, and therefore more oxygen, are reaching the tumours - making
the cancer less aggressive and less resistant to treatment.
Abnormal growth of blood vessels in solid tumors creates areas of hypoxia, which, in turn makes the tumors more aggressive and resistant to therapy. Exercise has been shown to improve blood vessel growth and perfusion of normal tissues and may have the same effect in solid tumors, according to a study published March 16 in the JNCI: Journal of the National Cancer Institute.
To
investigate the effect of exercise on tumor growth and response in
breast cancer, Allison S. Betof, of the Duke Cancer Institute, Duke
University Medical Center, Durham, NC, and Department of Internal
Medicine, Massachusetts General Hospital, Boston, MA, and colleagues
implanted breast cancer cells into mice and randomly assigned them to
wheel-running or sedentary groups. They then assessed tumor growth,
blood vessel density, maturity, and perfusion, extent of tumor hypoxia,
and response to a chemotherapeutic agent.
The researchers found
that after 18 days, compared to tumors in the sedentary group, those in
the exercise group had slower growth and higher blood vessel density,
maturity, and perfusion. Regions of hypoxia were 48.8% of tumor area in
the sedentary mice but only 25.5% in the exercised mice. When exercise
was combined with the chemotherapy drug cyclophosphamide, tumor growth
was slower than in sedentary mice as well as in mice subjected to
exercise alone or the drug alone.
However, the authors caution
that more work is needed to determine the effects of exercise on
slower-growing tumors and in combination with drugs or treatments
targeting tumor blood vessel growth.
The authors conclude, "...our
findings shed new insights into the potential anticancer role of
exercise as either adjuvant therapy or a combination therapeutic
strategy in patients with solid tumors."